DHR Stock Overview
Designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Danaher Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$228.55 |
| 52 Week High | US$281.70 |
| 52 Week Low | US$222.53 |
| Beta | 0.85 |
| 1 Month Change | -1.95% |
| 3 Month Change | -16.17% |
| 1 Year Change | -0.79% |
| 3 Year Change | -28.75% |
| 5 Year Change | 49.50% |
| Change since IPO | 25,674.82% |
Recent News & Updates
Danaher: A Resilient And Solid Company With Growth Potential
Dec 10Danaher (NYSE:DHR) Seems To Use Debt Quite Sensibly
Dec 08
Recent updates
Danaher: A Resilient And Solid Company With Growth Potential
Dec 10Danaher (NYSE:DHR) Seems To Use Debt Quite Sensibly
Dec 08Understanding Danaher's Cautiousness
Oct 25Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?
Sep 28Danaher Q3 Preview: Market Share Gains In Molecular Testing
Sep 25Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?
Sep 12Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly
Aug 28Danaher: Lofty Price, Bright Future
Aug 22Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings
Aug 13Danaher: Valuation Now Too High Even Compared To Own High Standards
Jul 16What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?
Jun 23Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum
Jun 20Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?
Jun 05Is Danaher (NYSE:DHR) A Risky Investment?
May 21It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year
May 01Value Vs. Growth? Danaher Says Why Not Both?
Apr 25Danaher: All In On Life Sciences, And Market Update
Mar 27Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?
Mar 11Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings
Feb 10Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term
Jan 30Is Danaher (NYSE:DHR) Using Too Much Debt?
Jan 12My Top 2024 Stock Pick: Danaher
Dec 27Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles
Nov 26RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing
Nov 19Why Danaher Is One Of My Favorite Long-Term Investments
Oct 26Danaher: Short-Term Headwinds, But Long-Term Tailwinds
Oct 17Should Danaher Investors Sell New Veralto Shares?
Oct 02Danaher: A Lost Year
Aug 30Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens
Aug 02Danaher: A Compounding Icon At A Fair Price
Jul 25Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump
Jun 22Shareholder Returns
| DHR | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -2.7% | -2.1% | -2.4% |
| 1Y | -0.8% | -5.5% | 23.3% |
Return vs Industry: DHR exceeded the US Life Sciences industry which returned -5.5% over the past year.
Return vs Market: DHR underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| DHR volatility | |
|---|---|
| DHR Average Weekly Movement | 3.1% |
| Life Sciences Industry Average Movement | 9.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DHR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: DHR's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 62,000 | Rainer Blair | www.danaher.com |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands.
Danaher Corporation Fundamentals Summary
| DHR fundamental statistics | |
|---|---|
| Market cap | US$163.35b |
| Earnings (TTM) | US$3.93b |
| Revenue (TTM) | US$23.74b |
42.0x
P/E Ratio7.0x
P/S RatioIs DHR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DHR income statement (TTM) | |
|---|---|
| Revenue | US$23.74b |
| Cost of Revenue | US$9.53b |
| Gross Profit | US$14.22b |
| Other Expenses | US$10.28b |
| Earnings | US$3.93b |
Last Reported Earnings
Sep 27, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.45 |
| Gross Margin | 59.87% |
| Net Profit Margin | 16.57% |
| Debt/Equity Ratio | 34.2% |
How did DHR perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield20%
Payout RatioDoes DHR pay a reliable dividends?
See DHR dividend history and benchmarks| Danaher dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Jan 31 2025 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 41 days |
Does DHR pay a reliable dividends?
See DHR dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 23:04 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/27 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Danaher Corporation is covered by 54 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Eade | Argus Research Company |
| Catherine Ramsey Schulte | Baird |
| Ishan Majumdar | Baptista Research |